Choi Jinhyun, Yoon Hong In, Lee Jeongshim, Keum Ki Chang, Kim Gwi Eon, Kim Yong Bae
Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University, College of Medicine, Seoul, Korea.
Department of Pharmacology, Brain Korea 21 plus Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
PLoS One. 2015 Dec 14;10(12):e0145158. doi: 10.1371/journal.pone.0145158. eCollection 2015.
The purpose of this study was to determine optimal extent of prophylactic irradiation of paraaortic lymph nodes (PALN) in patients with uterine cervical cancer who had metastatic pelvic LNs.
We retrospectively evaluated 103 patients with cervical cancer and pelvic lymph node metastasis who were treated with prophylactic semi-extended field radiotherapy (SEFRT) between 1990 and 2012. The semi-extended field included PALN below the second lumbar spine with prescribed doses of 45 to 50 Gy. Survival outcomes were calculated using the Kaplan-Meier method, and acute and late toxicities were scored using the Radiation Therapy Oncology Group and European Organisation for Research and Treatment of Cancer toxicity criteria.
The median follow-up after SEFRT was 61 (range 5-296) months. Overall, 28 patients (27.2%) experienced treatment failures, which were classified as local in 8 patients (7.8%), regional in 8 patients (7.8%), and distant in 13 patients (12.6%). Of the regional failures, only two involved PALN failure around the renal artery or the renal hilum area at the upper margin of the semi-extended field. At 5 years, the overall survival was 82%. Grade 3 or higher acute gastrointestinal and genitourinary toxicities occurred in one and two patients, respectively. As a late toxicity, one patient developed grade 3 small bowel obstruction.
Prophylactic SEFRT provided favorable outcomes with little acute or late gastrointestinal toxicity. For prophylaxis of PALN recurrences, upper part of PALN might not need to be included in patients with uterine cervical cancer and metastatic pelvic LNs.
本研究旨在确定子宫颈癌伴盆腔淋巴结转移患者腹主动脉旁淋巴结(PALN)预防性照射的最佳范围。
我们回顾性评估了1990年至2012年间接受预防性半扩大野放疗(SEFRT)的103例宫颈癌伴盆腔淋巴结转移患者。半扩大野包括第二腰椎以下的PALN,处方剂量为45至50 Gy。采用Kaplan-Meier法计算生存结局,并根据放射肿瘤学组和欧洲癌症研究与治疗组织的毒性标准对急性和晚期毒性进行评分。
SEFRT后的中位随访时间为61(5-296)个月。总体而言,28例患者(27.2%)出现治疗失败,其中8例(7.8%)为局部失败,8例(7.8%)为区域失败,13例(12.6%)为远处失败。在区域失败中,只有两例涉及半扩大野上缘肾动脉或肾门区域周围的PALN失败。5年时,总生存率为82%。分别有1例和2例患者发生3级或更高等级的急性胃肠道和泌尿生殖系统毒性。作为晚期毒性,1例患者发生3级小肠梗阻。
预防性SEFRT取得了良好的效果,急性或晚期胃肠道毒性较小。对于预防PALN复发,子宫颈癌伴盆腔淋巴结转移患者可能无需包括PALN的上部。